These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30802056)

  • 1. Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.
    Do HT; Li H; Chreifi G; Poulos TL; Silverman RB
    J Med Chem; 2019 Mar; 62(5):2690-2707. PubMed ID: 30802056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors.
    Vasu D; Li H; Hardy CD; Poulos TL; Silverman RB
    Bioorg Med Chem; 2022 Sep; 69():116878. PubMed ID: 35772285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
    Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.
    Do HT; Wang HY; Li H; Chreifi G; Poulos TL; Silverman RB
    J Med Chem; 2017 Nov; 60(22):9360-9375. PubMed ID: 29091437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability.
    Lawton GR; Ralay Ranaivo H; Chico LK; Ji H; Xue F; Martásek P; Roman LJ; Watterson DM; Silverman RB
    Bioorg Med Chem; 2009 Mar; 17(6):2371-80. PubMed ID: 19268602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.
    Xue F; Fang J; Delker SL; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2011 Apr; 54(7):2039-48. PubMed ID: 21410186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.
    Kang S; Li H; Tang W; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2015 Jul; 58(14):5548-60. PubMed ID: 26120733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors.
    Vasu D; Do HT; Li H; Hardy CD; Awasthi A; Poulos TL; Silverman RB
    J Med Chem; 2023 Jul; 66(14):9934-9953. PubMed ID: 37433128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
    Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
    Jing Q; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
    Bioorg Med Chem; 2013 Sep; 21(17):5323-31. PubMed ID: 23867386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.
    Cinelli MA; Li H; Chreifi G; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2014 Feb; 57(4):1513-30. PubMed ID: 24472039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase .
    Delker SL; Xue F; Li H; Jamal J; Silverman RB; Poulos TL
    Biochemistry; 2010 Dec; 49(51):10803-10. PubMed ID: 21138269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.
    Cinelli MA; Li H; Chreifi G; Poulos TL; Silverman RB
    J Med Chem; 2017 May; 60(9):3958-3978. PubMed ID: 28422508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase.
    Xue F; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6258-61. PubMed ID: 20833542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.
    Igarashi J; Li H; Jamal J; Ji H; Fang J; Lawton GR; Silverman RB; Poulos TL
    J Med Chem; 2009 Apr; 52(7):2060-6. PubMed ID: 19296678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
    Huang H; Silverman RB
    Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.
    Xue F; Huang J; Ji H; Fang J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
    Bioorg Med Chem; 2010 Sep; 18(17):6526-37. PubMed ID: 20673724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.
    Xue F; Fang J; Lewis WW; Martásek P; Roman LJ; Silverman RB
    Bioorg Med Chem Lett; 2010 Jan; 20(2):554-7. PubMed ID: 19963381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.
    Cinelli MA; Reidl CT; Li H; Chreifi G; Poulos TL; Silverman RB
    J Med Chem; 2020 May; 63(9):4528-4554. PubMed ID: 32302123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.
    Ji H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2009 Feb; 52(3):779-97. PubMed ID: 19125620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.